Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)

This study has been completed.
United States Department of Defense
Information provided by:
Hadassah Medical Organization Identifier:
First received: November 22, 2005
Last updated: February 17, 2009
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given